BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Influenza
,
Liver
,
Laryngoscope
,
Acetaminophen
,
rs2230926
,
PPARA
,
cell-cell adhesion
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
goblet cell adenocarcinoma
Summary
General Info
Curated Studies
Most Correlated Studies
Colorectal adenocarcinoma LS174T cells treated with nicotinamide adenine dinucleotide (NAD+)
Explore Curated Studies Results
Literature
Most Relevant Literature
Clinicopathological and molecular characterization of extra-appendix goblet cell adenocarcinomas.
Three Cases of Appendiceal Goblet Cell Adenocarcinoma in Our Institution].
Nonconventional Dysplasia is Frequently Associated With Goblet Cell Deficient and Serrated Variants …
Acute Appendicitis with Neuronal Hyperplasia and Swelling: A Novel Histologic Mimic of Appendiceal G…
Morphological Characteristics of Colon Tumors in Mice with Different Tolerance to Hypoxia.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Diagnostic Value of Diffusion-weighted Magnetic Resonance in High-risk Colorectal and Appendiceal Ne…
Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia
Phase I Trial HIPEC With Nal-irinotecan
The Microbiome, Bile Acids, and Notch in Barrett's Esophagus (BE)
A Study of Tegafur Combined With Temozolomide Versus Tegafur Combined With Temozolomide and Thalidom…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ